Physicochemical Properties
| Molecular Formula | C21H22N2O2 |
| Molecular Weight | 334.4116 |
| Exact Mass | 334.168 |
| CAS # | 2306039-66-5 |
| PubChem CID | 149706874 |
| Appearance | Off-white to light yellow solid powder |
| LogP | 4.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 25 |
| Complexity | 419 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O(C([H])([H])[H])C1C([H])=C([H])C(=C([H])C=1C([H])([H])[H])C1C([H])=C([H])C(N([H])[H])=NC=1C1C([H])=C([H])C(=C(C([H])([H])[H])C=1[H])OC([H])([H])[H] |
| InChi Key | AUHCLHXXUVPUBD-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C21H22N2O2/c1-13-11-15(5-8-18(13)24-3)17-7-10-20(22)23-21(17)16-6-9-19(25-4)14(2)12-16/h5-12H,1-4H3,(H2,22,23) |
| Chemical Name | 5,6-bis(4-methoxy-3-methylphenyl)pyridin-2-amine |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | The treatment of H1299-WSB1 cells with WSB1 Degrader 1 (compound 4; 0.25-2500 nM; 2-24 hours) causes WSB1 degradation in a dose- and time-dependent manner[1]. In KHOS and H460 cell lines, WSB1 Degrader 1 (compound 4) demonstrates strong antimigration efficacy with IC50 values of 39.1 μM and 24.47 μM, respectively[1]. In KHOS cells, WSB1 Degrader 1 (compound 4) dramatically reduces the migration of cancer cells in both normoxia and hypoxia. When KHOS cells are exposed to hypoxia, WSB1 Degrader 1 (5 μM) treatment increases the levels of RhoGDI2 protein[1]. Applying WSB1 Degrader 1 to H1299-WSB1 cells significantly reduces their ability to heal wounds. The A2780-WSB1/KO cells are not able to have their wound-healing ability blocked by WSB1 Degrader 1; only the wild-type A2780 (A2780-WT) cells are[1]. |
| ln Vivo | Treatment with WSB1 Degrader 1 (compound 4; 100 mg/kg; po; daily; for 28 days) can successfully prevent cancer cells from metastasizing to the lungs[1]. WSB1 Degrader 1 (compound 4) was administered to rats orally at a dose of 100 mg/kg or intraperitoneally at a dose of 160 mg/kg. Both methods of administration were shown to have rapid absorption (Tmax) but rapid clearance (T1/2) for the oral dose. Additionally, appropriate blood exposure was demonstrated by the Cmax and AUC0-t values of WSB1 Degrader 1 in the oral or intraperitoneal dose groups[1]. |
| Cell Assay |
Western Blot Analysis[1] Cell Types: H1299-WSB1 cells Tested Concentrations: 0.25 nM, 2.5 nM, 25 nM, 250 nM, 2500 nM Incubation Duration: 2 hrs (hours), 4 hrs (hours), 6 hrs (hours), 8 hrs (hours), 12 hrs (hours), 24 hrs (hours) Experimental Results: Induced WSB1 degradation in time-dependent and dose-dependent manners. |
| Animal Protocol |
Animal/Disease Models: Balb/c (nu/nu) mice bearing highly metastatic 4T1 breast cancer cells[1]. Doses: 100 mg/kg/day Route of Administration: po; daily ; for 28 days Experimental Results: Effectively inhibited the pulmonary metastasis of cancer cells. |
| References |
[1]. Discovery of 5,6-Bis(4-methoxy-3-methylphenyl)pyridin-2-amine as a WSB1 Degrader to Inhibit Cancer Cell Metastasis. J Med Chem. 2021 Jun 1. |
Solubility Data
| Solubility (In Vitro) | DMSO: 25 mg/mL (74.76 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (6.22 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9903 mL | 14.9517 mL | 29.9034 mL | |
| 5 mM | 0.5981 mL | 2.9903 mL | 5.9807 mL | |
| 10 mM | 0.2990 mL | 1.4952 mL | 2.9903 mL |